Jonathan Allan, GENERAL COUNSEL & Corporate Secretary at Stoke Therapeutics, Inc. (STOK), sold 43,384 shares at $20.07 ($873K) on 2025-09-03, disclosed to the SEC on 2025-09-03.
Scheduled sale ($873k) by GENERAL COUNSEL & Corporate Secretary under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.00 | 850 | $17K | 1.9% |
| 2 | $20.14 | 14,922 | $301K | 34.4% |
| 3 | $20.14 | 14,922 | $301K | 34.4% |
| 4 | $20.07 | 6,345 | $127K | 14.6% |
| 5 | $20.07 | 6,345 | $127K | 14.6% |
| Total | $20.12 avg | 43,384 |
| $873K |
| 100% |
| Filing → |
| STOK | SELL | 2026-06-18 | $44K | — | Filing → |
| STOK | SELL | 2026-03-24 | $626K | — | Filing → |
| STOK | SELL | 2026-03-19 | $569K | — | Filing → |